An interventional study of Nasogastric tube placement in Bronchiolitis, sponsored by Arkansas Children's Hospital Research Institute. Status unknown at 1 site in United States. Open to participants aged 1 Day to 23 Months, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-02-22.
Sponsored by Arkansas Children's Hospital Research Institute · Not applicable, Interventional, and Treatment
This study aims to evaluate whether placing nasogastric tubes for gastric decompression improves respiratory distress for patients with bronchiolitis who are receiving oxygen via high-flow nasal cannula.
All patients will be consented per IRB procedure. The study will be a prospective study. Study participants will be enrolled after placement on high flow nasal cannula. The respiratory therapist or study staff will use a bronchiolitis scoring tool, the Marlais Risk of Admission Score, to assess the respiratory status of patients after placement on high flow nasal cannula, and prior to placement of NG tube to establish a baseline measurement. This tool includes the following components: respiratory rate, oxygen saturation, heart rate, age, and length of illness. An NG tube will then be placed. Thirty minutes and sixty minutes after placement of the NG tube, the respiratory therapist or study team will again use this scoring tool to assess the respiratory status of the patient. After 60 minutes the study will be concluded. As subject will be requiring oxygen use, admission to an inpatient unit is required. The NG tube will be removed at the discretion of the provider or the admitting physician, who may choose to keep it in at their discretion.
365 studies on the registry are indexed under Bronchiolitis; 45 are open to participants now.
This study's planned enrollment of 60 is below the median of 80 across 251 interventional studies indexed under Bronchiolitis.
Browse Bronchiolitis studies →Arkansas Children's Hospital Research Institute is the lead sponsor of 122 studies on the registry; 25 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Device: Nasogastric tube placement
All patients enrolled in the study will have a nasogastric tube placed for gastric decompression.
Respiratory status
A bronchiolitis scoring tool, the Marlais Risk of Admission Score, will be used to assess the respiratory status of patients. This tool includes the following components: respiratory rate, oxygen saturation, heart rate, age, and length of illness.
Time frame: 60 minutes
Started Aug 2020 (actual). Primary completion is estimated for Apr 2024, 43 months after the start.
Of 58 non-industry interventional studies with no phase under Bronchiolitis, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 31. This study's planned 43 months is above that.
Counting every sponsor, half of 60 studies reached it within 15 months; a quarter within 10 and three quarters within 31.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Jul 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Arkansas Children's Hospital Research Institute →